Press Release

Press Release

  • (2022-07-29) Aimedbio and GCcell collaborates on the next generation CAR-NK cell therapy development
  • - Aimedbio and GC cell signs a co-development agreement for a CAR-NK cell therapy drug

    - The contract aims to derive candidates for CAR-NK drugs using Aimedbio’s 'AMB015' antibodies that bind to cancer-specific proteins.
    - Through this collaboration, Aimedbio hopes to expand their antibody-based therapeutics development area from ADCs to cell therapy.


    Link to full news:

Contact Us >>